Scalable Wastewater Surveillance for Routine and Emerging Infectious Disease Pathogens
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
CDC OFFICE OF ACQUISITION SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
75D301-26-R-73493
NAICS
541380 - Testing Laboratories and Services
Classification Code
Q301
Additional Details
Documents5
The Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services, has issued a solicitation for "Scalable Wastewater Surveillance for Routine and Emerging Infectious Disease Pathogens." This procurement seeks to establish an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to support the CDC’s ongoing efforts in public health surveillance through advanced wastewater testing. The primary objective is to enhance the nation’s capacity to detect, monitor, and respond to both routine and emerging infectious disease threats by leveraging wastewater analysis as a scalable and adaptable surveillance tool.
The scope of this solicitation encompasses comprehensive laboratory testing services, as classified under NAICS code 541380 (Testing Laboratories and Services), with a focus on the detection of infectious disease pathogens in wastewater. The contract will facilitate the implementation of robust surveillance systems capable of providing timely and actionable data to inform public health interventions. The inclusion of Task 6: Implementation, as noted in the most recent update to the IDIQ RFP, underscores the CDC’s commitment to operationalizing these surveillance capabilities at scale.
Key requirements for this procurement include the ability to perform high-throughput laboratory analyses, adherence to rigorous quality assurance protocols, and compliance with all applicable federal guidelines. Contractors will be expected to deliver comprehensive testing services, data management, and reporting solutions that align with CDC’s standards for public health surveillance. Additionally, the solicitation references an AI Use Compliance and Risk Management Plan, indicating that contractors must address considerations related to the ethical and secure use of artificial intelligence in the execution of contract tasks.
The place of performance for this contract is Atlanta, Georgia, reflecting the CDC’s central role in coordinating national public health initiatives from its headquarters. The procurement is not set aside for any specific business category, allowing for full and open competition among qualified entities. The Product Service Code associated with this opportunity is Q301, further specifying the requirement for laboratory testing services.
Interested parties should note that the contracting activity is managed by the CDC Office of Acquisition Services. The primary point of contact for this solicitation is Henrietta Fumbah, who can be reached at [email protected] or by phone at 770-488-8239. The solicitation is currently active, with a response deadline of September 2, 2026.
Contractors considering this opportunity should evaluate their capacity to deliver scalable, high-quality laboratory testing services for infectious disease surveillance, including the integration of advanced data analytics and compliance with AI risk management protocols. This contract represents a significant opportunity to contribute to national public health preparedness and response efforts through innovative wastewater surveillance solutions.
For further details and access to solicitation documents, interested vendors are encouraged to visit the official notice on SAM.gov at: https://sam.gov/opp/7a0102ee57aa49d0a42d5f455c6cd3b1/view.